Zobrazeno 1 - 10 of 89 pro vyhledávání: '"Harold S. Minkowitz"'
2
Opioid-Free Recovery After Hernia Repair with HTX-011 as the Foundation of a Non-Opioid, Multimodal Analgesia Regimen in a Real-World Setting: A Randomized, Open-Label Study
Autor: John Fanikos, Roy G. Soto, Gregory B. Hammer, Neel Mehta, Jia Hu, Jay Redan, Harold S. Minkowitz
Publikováno v: Pain and Therapy
Introduction Helping Opioid Prescription Elimination (HOPE) is a project designed to provide surgeons with practical, real-world solutions to effectively manage postoperative pain and eliminate the need for opioids using HTX-011 (extended-release bup
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e46327b125b48ba035a376d0b501b315
https://doi.org/10.1007/s40122-021-00289-2
Zobrazit plný text záznamu
3
A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a bupivacaine hydrochloride implant in patients undergoing abdominoplasty
Autor: Alina C Beaton, Daneshvari Solanki, Hernan Salazar, Steve Folkerth, Neil Singla, Harold S Minkowitz, David Leiman, Ben Vaughn, Nina Skuban, Gwendolyn Niebler
Publikováno v: Regional Anesthesia & Pain Medicine. :rapm-2022
IntroductionSurgical site infiltration with bupivacaine hydrochloride (HCl) is a standard element of postoperative analgesia for soft tissue surgeries, but results in short-lived analgesia. A novel bupivacaine implant, XARACOLL (bupivacaine HCl), is
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fe0271e42eb328a72dd7039581e3c157
https://doi.org/10.1136/rapm-2022-104110
Zobrazit plný text záznamu
4
Opaganib in Coronavirus Disease 2019 Pneumonia: Results of a Randomized, Placebo-Controlled Phase 2a Trial
Autor: Kevin L, Winthrop, Alan W, Skolnick, Adnan M, Rafiq, Scott H, Beegle, Julian, Suszanski, Guenther, Koehne, Ofra, Barnett-Griness, Aida, Bibliowicz, Reza, Fathi, Patricia, Anderson, Gilead, Raday, Gina, Eagle, Vered Katz, Ben-Yair, Harold S, Minkowitz, Mark L, Levitt, Michael S, Gordon
Publikováno v: Open Forum Infectious Diseases. 9
Background Opaganib, an oral sphingosine kinase-2 inhibitor with antiviral and anti-inflammatory properties, was shown to inhibit severe acute respiratory syndrome coronavirus 2 replication in vitro. We thus considered that opaganib could be benefici
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68f33875e2beb27da2f8d2f5e869c44f
https://doi.org/10.1093/ofid/ofac232
Zobrazit plný text záznamu
5
Pharmacokinetics and Safety of INL-001 (Bupivacaine HCl) Implants Compared with Bupivacaine HCl Infiltration After Open Unilateral Inguinal Hernioplasty
Autor: Gwendolyn Niebler, David A. Leiman, Harold S. Minkowitz
Publikováno v: Advances in Therapy
Introduction Surgical site infiltration with bupivacaine HCl results in short-lived analgesia for postsurgical pain and carries the risk of systemic bupivacaine toxicity due to accidental intravascular injection. INL-001 is a bupivacaine HCl collagen
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a665300b7eba338c66f42276ed144515
https://doi.org/10.1007/s12325-020-01565-x
Zobrazit plný text záznamu
6
Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting
Autor: Daniel Lipman, Kumar G. Belani, Sabry Ayad, Traci L. Hedrick, Linda Beagley, Sergio D. Bergese, Ashraf S. Habib, Marina Englesakis, Tricia A. Meyer, John Morton, Beverly K. Philip, Zhaosheng Jin, Pierre Diemunsch, Frances Chung, Harold S. Minkowitz, Tong J. Gan, Anthony L. Kovac, Samuel Lee, Richard D. Urman, Keith A. Candiotti, Peter Kranke, Christian C. Apfel
Publikováno v: Anesthesia & Analgesia. 131:411-448
This consensus statement presents a comprehensive and evidence-based set of guidelines for the care of postoperative nausea and vomiting (PONV) in both adult and pediatric populations. The guidelines are established by an international panel of exper
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dd2dda363729b61a0d6cf75699834f19
https://doi.org/10.1213/ane.0000000000004833
Zobrazit plný text záznamu
7
IV Tramadol – A New Treatment Option for Management of Post-Operative Pain in the US: An Open-Label, Single-Arm, Safety Trial Including Various Types of Surgery
Autor: Neil Singla, Scott A Reines, David A. Leiman, Mark Harnett, Michael Ryan, Lucy Lu, Harold S. Minkowitz
Publikováno v: Journal of Pain Research
Purpose There is a need to reduce exposure to Schedule II opioids in the United States (US) due to the ongoing opioid epidemic. Schedule II opioids have higher potential for abuse and misuse than Schedule IV opioids. This Phase 3, multicenter, single
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b0ed6d3e5d71a14fd49ed32129c7dba
https://doi.org/10.2147/jpr.s251175
Zobrazit plný text záznamu
8
Intravenous Tramadol is Effective in the Management of Postoperative Pain Following Abdominoplasty: A Three-Arm Randomized Placebo- and Active-Controlled Trial
Autor: Mark Harnett, Michael Ryan, Harold S. Minkowitz, Daneshvari Solanki, Hernan Salazar, Neil Singla, Lucy Lu, David A. Leiman, Scott A Reines
Publikováno v: Drugs in R&D, Vol 20, Iss 3, Pp 225-236 (2020)
Drugs in R&D
Background and Objective Oral tramadol, an atypical opioid approved in the United States (US) since 1995 and a Schedule IV controlled substance, has less abuse liability compared to Schedule II conventional opioids. Intravenous (IV) tramadol is not a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01de97d4be775d2d67bf75e7a97eb08c
https://doaj.org/article/c56bd93c3d8c485392b8778f0109b340
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje